Genes associated with Alzheimer's disease: an overview and current status

Código QR

Genes associated with Alzheimer's disease: an overview and current status

Mohan Giri, Man Zhang, Yang Lü Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, People’s Republic of China Abstract: Alzheimer’s disease (AD) is a progressive, neurodegenerative disease and the most c...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Giri M, Zhang M, Lü Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Alzheimer disease Amyloid precursor protein Genome wide association studies Biological pathways Presenilin 1 Presenilin 2 Neuropathology Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/a6733414e6914da89f2895a440fe667f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The genetics of Alzheimer's disease
por: Bagyinszky E, et al.
Publicado: (2014)

Mutations, associated with early-onset Alzheimer’s disease, discovered in Asian countries
por: Bagyinszky E, et al.
Publicado: (2016)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

A case of possibly pathogenic PSEN2 R62C mutation in a patient with probable early-onset Alzheimer’s dementia supported by structure prediction
por: Park KW, et al.
Publicado: (2017)

A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease
por: Giau VV, et al.
Publicado: (2018)

Long noncoding RNAs and Alzheimer's disease
por: Luo Q, et al.
Publicado: (2016)

An insight into Alzheimer’s disease and its on-setting novel genes
por: Jaanaky Vigneswaran, et al.
Publicado: (2021)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

Rehabilitating a brain with Alzheimer's: a proposal
por: Gonzalo Emiliano Aranda-Abreu, et al.
Publicado: (2011)

Presenilin1 inhibits glioblastoma cell invasiveness via promoting Sortilin cleavage
por: Wei Yang, et al.
Publicado: (2021)

Modulatory Effects of Alpha- and Gamma-Tocopherol on the Mitochondrial Respiratory Capacity and Membrane Potential in an In Vitro Model of Alzheimer’s Disease
por: Aslina Pahrudin Arrozi, et al.
Publicado: (2021)

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease
por: Zhang YY, et al.
Publicado: (2013)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

Presenilin 2 overexpression is associated with apoptosis in Neuro2a cells
por: Kumar Ashish, et al.
Publicado: (2016)

Study of Histopathological Lesions in CA1 of the Hippocampus after Injection of Beta-Amyloid in a Rat Model of Alzheimer’s Disease
por: SM Hoseini,, et al.
Publicado: (2012)

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
por: Ferris SH, et al.
Publicado: (2013)

Electroencephalography-driven approach to prodromal Alzheimer's disease diagnosis: from biomarker integration to network-level comprehension
por: Moretti DV
Publicado: (2016)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari S, et al.
Publicado: (2019)

Alzheimer disease: 100 years later
por: Puglielli MD,Luigi, et al.
Publicado: (2001)

Rivastigmine in the treatment of Alzheimer's disease: an update
por: Maria Luisa Onor, et al.
Publicado: (2007)

Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
por: Cai Z, et al.
Publicado: (2013)

Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology
por: Sacco G, et al.
Publicado: (2012)

Pathway Association Studies Reveal Gene Loci and Pathway Networks that Associated With Plasma Cystatin C Levels
por: Hongxiao Jiao, et al.
Publicado: (2021)

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

Model Identifies Genetic Predisposition of Alzheimer’s Disease as Key Decider in Cell Susceptibility to Stress
por: Ioanna C. Stefani, et al.
Publicado: (2021)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

Insilico Functional Analysis of Genome-Wide Dataset From 17,000 Individuals Identifies Candidate Malaria Resistance Genes Enriched in Malaria Pathogenic Pathways
por: Delesa Damena, et al.
Publicado: (2021)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş O, et al.
Publicado: (2015)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Subramanian Madhusoodanan, et al.
Publicado: (2008)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li XH, et al.
Publicado: (2015)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)

Care pathways for dementia: current perspectives
por: Samsi K, et al.
Publicado: (2014)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Perspectivas en la prevención y tratamiento farmacológico de la enfermedad de Alzheimer
por: Archibaldo Donoso,S, et al.
Publicado: (2009)